Activation of interferon-inducible 2'-5' oligoadenylate synthetase by adenoviral VAI RNA
- PMID: 7531709
- DOI: 10.1074/jbc.270.7.3454
Activation of interferon-inducible 2'-5' oligoadenylate synthetase by adenoviral VAI RNA
Abstract
2'-5' oligoadenylate (2-5(A)) synthetase and protein kinase, RNA activated (PKR) are the only two known enzymes that bind double-stranded RNA (dsRNA) and get activated by it. We have previously identified their dsRNA binding domains, which do not have any sequence homology. Here, we report a profound difference between the two enzymes with respect to the structural features of the dsRNA that are required for their activation. The adenoviral virus-associated type I (VAI) RNA cannot activate PKR, although it binds to the protein and thereby prevents its activation by authentic dsRNA. In contrast, we observed that VAI RNA can both bind and activate 2-5(A) synthetase. Mutations in VAI RNA, which removed occasional mismatches present in its double-stranded stems, markedly enhanced its 2-5(A) synthetase-activating capacity. These mutants, however, are incapable of activating PKR. Other mutations, which disrupted the structure of the central stem-loop region of the VAI RNA, reduced its ability to activate 2-5(A) synthetase. These debilitated mutants could bind to the synthetase protein, although they fail to bind to PKR.
Similar articles
-
In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain.J Virol. 1994 Jul;68(7):4137-51. doi: 10.1128/JVI.68.7.4137-4151.1994. J Virol. 1994. PMID: 7911532 Free PMC article.
-
Regulation of the interferon-inducible protein kinase PKR and (2'-5')oligo(adenylate) synthetase by a catalytically inactive PKR mutant through competition for double-stranded RNA binding.Eur J Biochem. 1995 May 15;230(1):97-103. doi: 10.1111/j.1432-1033.1995.0097i.x. Eur J Biochem. 1995. PMID: 7541351
-
Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.J Mol Biol. 2006 May 19;358(5):1270-85. doi: 10.1016/j.jmb.2006.03.003. Epub 2006 Mar 20. J Mol Biol. 2006. PMID: 16580685
-
On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR.Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):351-61. doi: 10.1016/j.cytogfr.2007.06.003. Epub 2007 Aug 2. Cytokine Growth Factor Rev. 2007. PMID: 17681872 Review.
-
Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases.J Interferon Res. 1991 Aug;11(4):199-205. doi: 10.1089/jir.1991.11.199. J Interferon Res. 1991. PMID: 1717615 Review.
Cited by
-
Antiviral actions of interferons.Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents. doi: 10.1128/CMR.14.4.778-809.2001. Clin Microbiol Rev. 2001. PMID: 11585785 Free PMC article. Review.
-
A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.Nucleic Acids Res. 2015 Jan;43(1):544-52. doi: 10.1093/nar/gku1289. Epub 2014 Dec 4. Nucleic Acids Res. 2015. PMID: 25477390 Free PMC article.
-
The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.Pharmacol Ther. 1998 May;78(2):55-113. doi: 10.1016/s0163-7258(97)00167-8. Pharmacol Ther. 1998. PMID: 9623881 Free PMC article. Review.
-
Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.Lung Cancer. 2007 Feb;55(2):145-56. doi: 10.1016/j.lungcan.2006.10.012. Epub 2006 Nov 17. Lung Cancer. 2007. PMID: 17113184 Free PMC article.
-
The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells.Virology. 2011 Jan 20;409(2):262-70. doi: 10.1016/j.virol.2010.10.016. Epub 2010 Nov 5. Virology. 2011. PMID: 21056894 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources